We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Microfluidic Device Created For Genetic Analysis

By LabMedica International staff writers
Posted on 17 Aug 2011
A silicone chip based apparatus has been generated that could make genetic analysis far more sensitive, rapid, and cost-effective. More...


The device, which is about the size of a nine-volt battery, allows simultaneously analysis of 300 individual cells by routing fluid carrying cells through microscopic tubes and valves.

Scientists at the University of British Columbia, (UBC; Vancouver, BC, Canada) isolated the cells into their separate chambers, and then extracted and replicated the cells' ribonucleic acid (RNA) for further analysis. The device's ease of use and cost-effectiveness arise from its integration of almost the entire process of cell analysis, not just separating the cells, but also mixing them with chemical reagents to highlight their genetic code and analyzing the results by measuring fluorescent light emitted from the reaction. All of that can now be done on the chip.

The fully integrated microfluidic device is capable of performing high-precision real-time quantitative polymerase chain reaction (RT-qPCR) measurements of gene expression from hundreds of single cells per run. The device executes all steps of single-cell processing, including cell capture, cell lysis, reverse transcription, and quantitative PCR. By enabling such "single-cell analysis," the device could accelerate genetic research and hasten the use of far more detailed tests for diagnosing cancer. The standard genetic tests, which require large numbers of cells, capture only an average composite picture of thousands or millions of different cells that may obscure their true nature and the interactions between them.

Carl Hansen, PhD, an assistant professor at UCB said, "This technology and other approaches like it could radically change the way we do both basic and applied biomedical research, and would make single-cell analysis a more plausible option for treating patients, allowing clinicians to distinguish various cancers from one another and tailor their treatments accordingly." The study was published August 1, 2011, in the Proceedings of the National Academy of Sciences of the United States of America (PNAS).

Related Links:

University of British Columbia




New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Staining Management Software
DakoLink
New
Automated Microscope
dIFine
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.